Description of 3 patients with myasthenia gravis and COVID-19

BACKGROUND: The COVID-19 pandemic presents two main concerns for patients with myasthenia gravis (MG); chronic immunosuppression may put them at greater risk, and some proposed treatments for COVID-19 could cause MG exacerbation. CASE DESCRIPTION: We present three patients with generalized seroposit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rein, Netaniel, Haham, Nitzan, Orenbuch-Harroch, Efrat, Romain, Marc, Argov, Zohar, Vaknin-Dembinsky, Adi, Gotkine, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Clinical Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832365/
https://www.ncbi.nlm.nih.gov/pubmed/32731059
http://dx.doi.org/10.1016/j.jns.2020.117053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832365/
https://www.ncbi.nlm.nih.gov/pubmed/32731059
http://dx.doi.org/10.1016/j.jns.2020.117053

Ejemplares similares